Brazil incentivises national production
This article was originally published in Scrip
State-owned pharmaceutical companies in Brazil are being asked to favour locally produced ingredients in a bid to stimulate domestic industry, says the health ministry. Health minister José Gomes Tempoão signed a decree to this effect at a recent event commemorating 90 years of the state-owned lab Farmanguinhos's medicine provision service. The move should stimulate innovation and the development of technology, said the minister.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.